KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Amortization - Intangibles (2016 - 2025)

Boston Scientific's Amortization - Intangibles history spans 17 years, with the latest figure at $228.0 million for Q4 2025.

  • For Q4 2025, Amortization - Intangibles rose 1.33% year-over-year to $228.0 million; the TTM value through Dec 2025 reached $897.0 million, up 4.79%, while the annual FY2025 figure was $897.0 million, 4.79% up from the prior year.
  • Amortization - Intangibles for Q4 2025 was $228.0 million at Boston Scientific, up from $225.0 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $228.0 million in Q4 2025 and bottomed at $180.0 million in Q2 2021.
  • The 5-year median for Amortization - Intangibles is $205.5 million (2022), against an average of $206.2 million.
  • The largest annual shift saw Amortization - Intangibles fell 8.63% in 2021 before it rose 13.33% in 2022.
  • A 5-year view of Amortization - Intangibles shows it stood at $192.0 million in 2021, then rose by 3.65% to $199.0 million in 2022, then grew by 4.02% to $207.0 million in 2023, then rose by 8.7% to $225.0 million in 2024, then rose by 1.33% to $228.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Amortization - Intangibles are $228.0 million (Q4 2025), $225.0 million (Q3 2025), and $225.0 million (Q2 2025).